Back to search results

A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure

Abroad (travel likely)RecruitingPHASE2

Conditions

Seasonal Allergic Rhinitis (SAR)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cliantha Research, Mississauga, Ontario, Canada

    Contact: Study coordinator (Patricia Couroux, MD) · pcouroux@cliantha.com · (905) 282-1808
    Contact: Principal Investigator (Patricia Couroux, MD)
Study leads

  • Patricia Couroux, MD

    Principal Investigator

    Cliantha Research

View source on ClinicalTrials.gov(opens in a new tab)